Ambalal Sarabhai [AMBALALSA] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison

Ambalal Sarabhai
BSE
Loading...

Sequent Scientific
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Ambalal Sarabhai wins in 10 metrics, Sequent Scientific wins in 8 metrics, with 0 ties. Ambalal Sarabhai appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Ambalal Sarabhai | Sequent Scientific | Better |
---|---|---|---|
P/E Ratio (TTM) | 52.80 | 155.79 | Ambalal Sarabhai |
Price-to-Book Ratio | 1.85 | 6.30 | Ambalal Sarabhai |
Debt-to-Equity Ratio | 36.35 | 62.47 | Ambalal Sarabhai |
PEG Ratio | N/A | 1.31 | N/A |
EV/EBITDA | 18.39 | 29.41 | Ambalal Sarabhai |
Profit Margin (TTM) | 6.50% | 1.85% | Ambalal Sarabhai |
Operating Margin (TTM) | 1.49% | 7.56% | Sequent Scientific |
EBITDA Margin (TTM) | 1.49% | 7.56% | Sequent Scientific |
Return on Equity | 3.52% | 2.84% | Ambalal Sarabhai |
Return on Assets (TTM) | 1.83% | 1.37% | Ambalal Sarabhai |
Free Cash Flow (TTM) | $-203.34M | $442.73M | Sequent Scientific |
1-Year Return | -44.52% | 5.41% | Sequent Scientific |
Price-to-Sales Ratio (TTM) | 1.31 | 2.77 | Ambalal Sarabhai |
Enterprise Value | $3.04B | $48.85B | Sequent Scientific |
EV/Revenue Ratio | 1.55 | 3.05 | Ambalal Sarabhai |
Gross Profit Margin (TTM) | 36.86% | 46.86% | Sequent Scientific |
Revenue per Share (TTM) | $25 | $64 | Sequent Scientific |
Earnings per Share (Diluted) | $0.64 | $1.14 | Sequent Scientific |
Beta (Stock Volatility) | -0.12 | 0.91 | Ambalal Sarabhai |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Ambalal Sarabhai vs Sequent Scientific Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Ambalal Sarabhai | 1.60% | 2.75% | -2.22% | -9.42% | -16.25% | -38.84% |
Sequent Scientific | -0.15% | 0.12% | -6.92% | -2.35% | 12.64% | -4.77% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Ambalal Sarabhai | -44.52% | 18.58% | 61.93% | 352.31% | 211.24% | 115.91% |
Sequent Scientific | 5.41% | 52.52% | 30.60% | 19.28% | 19.28% | 19.28% |
Performance & Financial Health Analysis: Ambalal Sarabhai vs Sequent Scientific
Metric | AMBALALSA | SEQUENT |
---|---|---|
Market Information | ||
Market Cap | ₹2.59B | ₹44.38B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 85,014 | 609,928 |
90 Day Avg. Volume | 67,996 | 532,456 |
Last Close | ₹34.33 | ₹175.85 |
52 Week Range | ₹30.00 - ₹69.75 | ₹117.35 - ₹240.70 |
% from 52W High | -50.78% | -26.94% |
All-Time High | ₹77.70 (Jul 08, 2024) | ₹336.50 (Jun 28, 2021) |
% from All-Time High | -55.82% | -47.74% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.01% | 0.13% |
Quarterly Earnings Growth | 22.69% | 1.20% |
Financial Health | ||
Profit Margin (TTM) | 0.07% | 0.02% |
Operating Margin (TTM) | 0.01% | 0.08% |
Return on Equity (TTM) | 0.04% | 0.03% |
Debt to Equity (MRQ) | 36.35 | 62.47 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹18.27 | ₹28.19 |
Cash per Share (MRQ) | ₹1.14 | ₹2.52 |
Operating Cash Flow (TTM) | ₹-299,709,000 | ₹360.47M |
Levered Free Cash Flow (TTM) | ₹49.31M | ₹218.78M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Ambalal Sarabhai vs Sequent Scientific
Metric | AMBALALSA | SEQUENT |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 52.80 | 155.79 |
Forward P/E | N/A | 35.17 |
PEG Ratio | N/A | 1.31 |
Price to Sales (TTM) | 1.31 | 2.77 |
Price to Book (MRQ) | 1.85 | 6.30 |
Market Capitalization | ||
Market Capitalization | ₹2.59B | ₹44.38B |
Enterprise Value | ₹3.04B | ₹48.85B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.55 | 3.05 |
Enterprise to EBITDA | 18.39 | 29.41 |
Risk & Other Metrics | ||
Beta | -0.12 | 0.91 |
Book Value per Share (MRQ) | ₹18.27 | ₹28.19 |
Financial Statements Comparison: Ambalal Sarabhai vs Sequent Scientific
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | AMBALALSA | SEQUENT |
---|---|---|
Revenue/Sales | ₹403.39M | ₹4.41B |
Cost of Goods Sold | ₹232.76M | ₹2.35B |
Gross Profit | ₹170.63M | ₹2.07B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹6.00M | ₹333.50M |
EBITDA | ₹98.21M | ₹505.30M |
Pre-Tax Income | ₹79.34M | ₹255.20M |
Income Tax | ₹-2.90M | ₹79.50M |
Net Income (Profit) | ₹82.24M | ₹175.70M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | AMBALALSA | SEQUENT |
---|---|---|
Cash & Equivalents | ₹48.95M | ₹626.60M |
Total Current Assets | ₹1.18B | ₹8.74B |
Total Current Liabilities | ₹1.20B | ₹5.05B |
Long-Term Debt | ₹90.15M | ₹3.00B |
Total Shareholders Equity | ₹1.40B | ₹7.70B |
Retained Earnings | ₹-28.33M | ₹1.25B |
Property, Plant & Equipment | ₹50.63M | ₹2.84B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | AMBALALSA | SEQUENT |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | AMBALALSA | SEQUENT |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 85,014 | 609,928 |
Average Daily Volume (90 Day) | 67,996 | 532,456 |
Shares Outstanding | 76.63M | 249.89M |
Float Shares | 47.56M | 117.77M |
% Held by Insiders | 0.34% | 0.53% |
% Held by Institutions | 0.00% | 0.13% |
Dividend Analysis & Yield Comparison: Ambalal Sarabhai vs Sequent Scientific
Metric | AMBALALSA | SEQUENT |
---|---|---|
Last 12-Month Dividend | N/A | ₹0.00 |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | ₹0.00 |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | ₹0.00 |
Ex-Dividend Date | N/A | N/A |